Presenter Name - PowerPoint PPT Presentation

About This Presentation
Title:

Presenter Name

Description:

The Opportunity for Comprehensive Medication Management Presenter Name * * * The problems point toward more underutilization of effective therapies than ... – PowerPoint PPT presentation

Number of Views:125
Avg rating:3.0/5.0
Slides: 36
Provided by: TML4
Category:

less

Transcript and Presenter's Notes

Title: Presenter Name


1
The Opportunity for Comprehensive Medication
Management
Presenter Name
2
Agenda
  • The Need for Medication Management Services
  • The PCMH Team as a Solution
  • The Steps of Comprehensive Medication Management
  • Impact of the Service
  • Payment Approaches
  • Case Studies

3
The Facts
  • 75 of all healthcare costs are related to
    chronic disease
  • After lifestyle interventions, medications are
    the primary weapons used in modern medicine to
    prevent disease and effectively control chronic
    disease
  • Proper use of medications can lead to improved
    health, enhanced quality of life, and increased
    productivity when directly linked to clinical
    outcome goals.

So Why A Quality Gap?
4
The Facts
  • Four out of Five patients leave with at least
    one prescription1
  • One-third of all American adults take 5 or more
    medications
  • Medicare beneficiaries with multiple illnesses
  • See an average of 13 different physicians
  • Have 50 different prescriptions filled each year
  • Account for 76 of all hospital admissions
  • Account for 88 of all prescriptions filled
  • Account for 72 of physician visits
  • Are 100 times more likely to have a preventable
    hospitalization than someone without a chronic
    condition2

1 The chain pharmacy industry profile. National
Association of Chain Drug Stores. 2001 2
Testimony of Gerard F. Anderson, Ph.D., Johns
Hopkins Bloomberg School of Public Health, Health
Policy and Management, before the Senate Special
Committee on Aging, 2 The Future of Medicare
Recognizing the Need for Chronic Care
Coordination, Serial No. 110-7, pp. 19-20 (May 9,
2007)
5
HealthCare Landscape
  • But what happens to those prescriptions?

Non-Compliant Behaviors
The Hidden Epidemic Finding a Cure for Unfilled
Prescriptions and Missed Doses. December, 2003.
The Boston Consulting Group and Harris
Interactive. Available at http//www.bcg.com/publ
ications/files/TheHiddenEpidemic_Rpt_HCDec03.pdf.
Accessed August 16, 2004.
6
Why Didnt They Take Their Medication?
  • 24 forgetfulness
  • 20 undesirable or debilitating side effects
  • 17 medication was too costly
  • 14 decided they didn't need the drug
  • 10 difficulties in getting the prescription
    filled

The Hidden Epidemic Finding a Cure for Unfilled
Prescriptions and Missed Doses, December, 2003.
The Boston Consulting Group and Harris
Interactive. Available at http//www.bcg.com/publ
ications/files/TheHiddenEpidemic_Rpt_HCDec03.pdf.
Accessed August 16, 2004.
7
The PCMH Team Closes The Quality Gap
  • Appropriate medications need to be recommended
    and prescribed,
  • Patients need to thoroughly understand, have
    access to, and engage with their medications
  • The most effective treatments (with continual
    evaluation modification) can produce optimal
    clinical and quality outcomes.

8
Why Is Medication Management Neededin the PCMH?
  • Comprehensive medication management has been
    shown to facilitate the efficiency and
    effectiveness of the PCMH team in improving
    patient clinical outcomes, reducing morbidity and
    mortality, while lowering total healthcare
    costs.
  • Medication Management is even more essential when
    multiple providers/prescribers are involved with
    complex patients

9
The Community Care NC Experience
  • Underutilization of controller medications in
    asthmatics and lack of adherence to medications
    in patients with congestive heart failure were
    major contributors to ER visits and
    hospitalizations.
  • Dr. Allen Dobson- Former NC Assistant Sec. of
    Health and State Medicaid Director

Informing the Future Critical Issues in Health,
Fourth Edition- Institute of Medicine 2007 pg.
13 http//www.nap.edu/catalog/12014.html
10
Group Health Cooperative
  • Most patient care interactions involve
    medications and the limitations both in knowledge
    and time on my part make the addition of a
    clinical pharmacist on the medical home team
    MANDATORY ! I would have a difficult time
    maintaining our current standards without this
    person on board.
  • James Bergman, M.D. Staff Physician,
  • Group Health Permanente, Associate
    Professor,
  • Family Medicine, University of Washington,
    Seattle

11
Comprehensive Medication Management in the PCMH
Core Principles of the Patient Centered Medical
Home

Elements of Comprehensive Medication Management
ASSESSMENT Reveal the patients medication
experience Identify drug therapy problems in
appropriateness of, effectiveness of, safety of,
and compliance with medications
  • CARE PLAN
  • Establish personalized goals of therapy
  • Resolve drug therapy problems
  • Personalize Interventions

FOLLOW-UP Effectiveness and Safety Determine
Actual Patient Outcomes
12
Comprehensive Medication Management in the PCMH
Clinical Pharmacist/ Pharmacotherapy Manager
Gaps in clinical goals are determined, drug
therapy problems identified, and therapeutic
recommendations made
Optimal therapeutic recommendations are based on
the experience/needs of the patient

Patient
Physicians/ Providers - PCMH
Appropriate, Effective, Safe and
Adherent Medication Use!
Patient understands his/her medications and
participates in a care plan to improve health
Clinical goals of therapy are determined and
medication recommendations are considered
13
Steps to Achieve Comprehensive MTM
  • 1) Identify patients that have not achieved
    clinical goals of therapy
  • 2) Understand the patients personal medication
    experience/history and preferences/beliefs
  • 3) Identify actual use patterns of all
    medications including OTCs, bioactive
    supplements, and prescribed medications
  • 4) Systematically review for drug interactions
    then assess each medication for appropriateness,
    effectiveness, safety and adherence (in that
    order) focused on achievement of the clinical
    goals for each therapy

14
Steps to Achieve Comprehensive MTM
  • 5) Identify all drug therapy problems (the gap
    between current therapy and that needed to
    achieve optimal clinical outcomes)
  • 6) Develop a care plan addressing recommended
    steps including therapeutic changes needed to
    achieve optimal outcomes
  • 7) Patient agrees with and understands care plan
    which is communicated to the prescriber/provider
    for his/her consent/support

15
Steps to Achieve Comprehensive MTM
  • 8) Document all steps and current clinical status
    vs. goals of therapy
  • 9) Follow-up evaluations with the patient are
    critical to determine effects of changes,
    reassess actual outcomes, and recommend further
    therapeutic changes to achieve desired clinical
    goals/outcomes
  • 10) A reiterative process - care is coordinated
    with other team members and personalized (patient
    unique) goals of therapy understood

16
Self-insured Employer The Diabetes 10 City
Challenge - Outcomes
  • Decrease in A1C (5.2), LDL (32), SBP (15.7),
    DBP (9.2)
  • Increase in nutrition, exercise, and weight loss
    goals
  • Employer savings of 918 per employee in total
    health care costs
  • ROI of at least 41 beginning in the second year
  • 50 reduction in absenteeism and fewer workers
    compensation claims
  • 97.5 of patients reported being satisfied or
    very satisfied with their diabetes care
  • http//www.diabetestencitychallenge.com/
  • Fera T, Bluml BM, Ellis WM. Diabetes ten city
    challenge Final economic and clinical results.
  • JAmPharmAssoc 2009, 49383-91.

17
Return on Investment
  • Asheville Project - Pharmacist MTM program for
    diabetics saved 1200/pt/yr with improved
    outcomes
  • Bunting BA, Cranor CW. The Asheville project
    long term, clinical, humanistic, and economic
    outcomes of a community based medication therapy
    management program for asthma. J Am Pharm. Assoc
    200646133-47.
  • Scope of MTM services provided in some
    programs may differ from the comprehensive
    framework described and recommended for the PCMH.

18
Return on Investment (cont.)
  • Minnesota MTM program resolved 3.1 drug therapy
    problems per recipient generating average cost
    savings of approx. 403/pt/yr
  • Isetts BJ. Evaluating effectiveness of the
    Minnesota medication therapy management care
    program. Final Report. Available at
    http//www.dhs.state.mn.us/main/groups/business_pa
    rtners/documents/pub/dhs16_140283.pdf.

19
Return on Investment (cont)
  • On average, 16.70 saved for every 1 invested in
    clinical pharmacy services (review of 104
    studies)
  • Bussey HI. Blood, sweat, and tears Wasted by
    Medicares missed opportunities. Pharmacotherapy
    2004241655-58.
  • Benefit cost ratio ranged from 1.71 - 17.01
    (literature review).
  • Schumock GT, Butler MG, Meek PD, Vermeulen LC,
    Arondekar BV, Bauman JL. 2002 Task Force on
    Economic Evaluation of clinical Pharmacy Services
    of the American College of Clinical Pharmacy.
    Evidence of the economic benefit of clinical
    pharmacy services 1996-2000. Pharmacotherapy.
    2003 Jan, 23(1)113-32.

20
Impact of Comprehensive Medication ManagementThe
Patients Perspective
  • I have been taking this medication for almost
    seven years. I have never been clear on why I am
    taking it or what it is supposed to do for me,
    and, I have never had anyone who had the time to
    explain it to me. Now I can ask questions and
    discuss my concerns about my medications.
  • J.P. (Patient receiving medication
    management services at a medicine clinic in
    Minneapolis, MN)

A thorough understanding of patients illnesses
and how medications impact outcomes is critical
for truly Patient Centered Care.
21
Payment for Medication Management Services
  • The following recognize and are providing payment
    for the service
  • The Federal Government in Medicare Part D
  • State Medicaid Governments (for example,
    Minnesota, North Dakota, New York,)
  • Employers (e.g., General Mills)
  • Commercial plans
  • Mechanisms for Payment
  • Current Procedural Terminology (CPT) Codes for
    pharmacist-provided MTM services
  • Evaluation and Management (EM) CPT Codes
  • Capitated Payment Methodologies
  • Fee-for-service/Self-pay by patients

21
22
Pharmaceuticals are the most common medical
intervention, and their potential for both help
and harm is enormous. Ensuring that the American
people get the most benefit from advances in
pharmacology is a critical component of improving
the national health care system.The Institute
of Medicine (IOM)1 Drugs Dont Work in People
that Dont Take ThemC. Everett Koop, MDFormer
Surgeon General
1 The Institute of Medicine, National Academy of
Sciences. Informing the future Critical
issues in health. Fourth edition, page 13.
http//www.nap.edu/catalog/12014.html
22
23
Thank You and Join the Collaborative!
  • To request any additional information on the
    PCMH or the Patient Centered Primary Care
    Collaborative please contact Edwina Rogers,
    Executive Director
  • erogers_at_pcpcc.net, (202)724-3331
  • Visit our website http//www.pcpcc.net

24
Case Studies
24
25
Community Care of North Carolina
  • Focus on improved quality, utilization and cost
    effectiveness of chronic illness care
  • 15 Networks with more than 3500 Primary Care
    Physicians (1000 medical homes) and over 950,000
    enrollees

L. Allen Dobson ,Jr. MD FAAFP Former Assistant
Secretary NC Department of Health Human Services
26
Community Care of North Carolina
  • In 2009 Each Network Now Has
  • Part-time paid Medical Director - role is
    oversight of quality efforts, meets with
    practices and serves on State Clinical Committee
  • Clinical Coordinator - oversees the overall
    network operations
  • Care Managers - small practices share/large
    practices may have their own assigned
  • All networks have a pharmacist to assist with
    medication management of high cost patients (MTM)

L. Allen Dobson ,Jr. MD FAAFP Former Assistant
Secretary NC Department of Health Human Services
27
North Carolina Medicaid State Fiscal Year 2004
Savings
Category of Service Estimated Savings from Benchmark
Inpatient 142,085,680
Outpatient 51,865,028
Emergency Room 25,944,553
Primary Care, Specialist 45,498,709
Pharmacy (15,526,996)
Other (5,065,238)
Totals 244,801,735
28
North Carolina Clinical Results
  • Asthma
  • 40 decrease in hospital admission rate
  • 16 lower ED rate
  • 93 received appropriate maintenance medications
  • Diabetes
  • 15 increase in quality measures
  • Pilots now include the addition of the Aged,
    Blind, and Disabled and Medicare (646 waiver)
    pending!

Source CC_NC 2007 Asthma Disease Management
Program Summary
29
The Minnesota MTM experience
  • Patients Targeted
  • 1 of 12 Chronic Conditions in Adults 18-64 and
  • 2 or more health care claims (related to those
    conditions) in the last 12 months
  • 285 MTM patients and 252 comparison group all
    BCBS Minnesota health plan members
  • Fairview Health System clinics and MTM
    pharmacists
  • 6.4 medical conditions and 7.9 drug therapies per
    MTM patient

Isetts, et al. J Am Pharm Assoc.
200848(2)203-211)
30
Minnesota MTM Process of Care Overview
  • Patient-centered with a clinical pharmacist
  • Consistent and systematic process that
  • Assessed all of the patients drug-related needs
  • Identified drug therapy problems
  • Established therapeutic goals
  • Designed a medication therapy care plan
  • Conducted follow-up visits to evaluate progress
  • Communicated information to the patients
    physician or provider
  • Linked Medication use to clinical outcome
    improvement

31
The Minnesota Experience 637 Drug Therapy
Problems Identified
Needs Additional Drug Therapy 34
Unnecessary Drug Therapy
6 Ineffective Drug 12 Dosage Too Low
20 Adverse Drug Reaction 14 Dosage Too
High 4 Noncompliance 10
100
Indication
Effectiveness
Safety
Compliance
Source Isetts, et al. J Am Pharm Assoc.
200848(2)203-211
32
Economic Outcomes of Minnesota MTMTarget the
Disease, Then Optimize the Drug Therapy
  • Total health care cost -31.5
  • Facility costs -57.9
  • Professional costs -11.1
  • Drug costs 19.7

MTM services provided a 121 ROI
Isetts, et al. J Am Pharm Assoc.
200848(2)203-211)
33
Economic Outcomes of MTM Services Summary The
Minnesota Experience
  • Total annual health care cost reduced by 31.5
    post MTM from 11,965 to 8,197 (drug costs
    slightly increased with 12 increase in Rx
    claims)
  • MTM services delivered and documented by
    Assurance Pharmaceutical Care System generated
    121 ROI

Source Isetts, et al. J Am Pharm Assoc.
200848(2)203-211
34
Clinical Outcomes of Minnesota MTM Services
  • Clinical Results Improved!
  • Goals of therapy improved from baseline 76 to
    90 after MTM
  • 2.2 drug therapy problems per patient identified
    and resolved 78 resolved without MD
  • HEDIS Hypertension criteria achieved in 71 of
    MTM patients versus 59 comparison group
  • HEDIS Cholesterol criteria achieved in 52 of
    MTM patients versus 30 comparison group

Isetts, et al. J Am Pharm Assoc.
200848(2)203-211)
35
Best Practice 1) Targeted Patients with
Chronic Conditions 2) Linked MTM to Clinical
Goals in a team approach
Isetts, et al. J Am Pharm Assoc.
200848(2)203-211)
Write a Comment
User Comments (0)
About PowerShow.com